Drugs Made In America Acquisition II Financial Ratios
NASDAQ: DMIIFinanceBlank ChecksUSD
10.190.00 (0.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Drugs Made In America Acquisition II ratio analysis
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Drugs Made In America Acquisition II financial ratios (annual)
| Ratio | FY 2025 |
|---|---|
| Return on assets (ROA) | 0.8% |
| Current ratio | 0.09 |